$1.270
+0.132 (+10.43%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Cellectar Biosciences Inc (CLRB) Moving Averages Convergence Divergence (MACD) indicator is -0.14, suggesting CLRB is Sell.
Cellectar Biosciences Inc (CLRB) 20-Day simple moving average is 1.23, while Cellectar Biosciences Inc (CLRB) share price is $—, making it Buy.
Cellectar Biosciences Inc (CLRB) 60-Day simple moving average is 1.89, while Cellectar Biosciences Inc (CLRB) share price is $—, making it Sell.
Technical Analysis for CLRB
AI Technical CLRBAs of 2026-11-07, the technical board for Cellectar Biosciences Inc (CLRB) reads sell: 4 indicators are flashing buy, 5 are indicating sell, and 4 are neutral. Price at $1.27 sits below the 60-day and 200-day moving averages and above the 5-day, 10-day and 20-day.
Momentum readings: RSI stands at 40.46, MACD stands at -0.14 (Sell), Stochastic %K stands at 37.744, Stochastic %D stands at 47.395 and CCI stands at -29.96.
CLRB trades below the 60-day SMA (1.89) and below the 200-day SMA (2.57). Immediate resistance sits at Classic R1 1.36, then R2 1.49. Support sits at Classic S1 1.10, then S2 0.97.
Cellectar Biosciences Inc (CLRB) Support & Resistance Level
Cellectar Biosciences Inc (CLRB) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 40.460 |
| STOCHk_14_3_3 | 37.744 |
| STOCHd_14_3_3 | 47.395 |
| CCI_20 | -29.960 |
| AO_5_34 | -0.249 |
| MOM_10 | 0.030 |
| MACD_12_26_9 | -0.140 |
Cellectar Biosciences Inc (CLRB) Relative Strength Index (RSI_14) is 40.460, creating a Neutral signal.
Cellectar Biosciences Inc (CLRB) Stochastic %K is 37.744, creating a Neutral signal.
Cellectar Biosciences Inc (CLRB) Stochastic %D is 47.395, creating a Neutral signal.
Cellectar Biosciences Inc (CLRB) CCI_20 is -29.960, creating a Neutral signal.
Cellectar Biosciences Inc (CLRB) Awesome Oscillator (AO) is -0.249, creating a Sell signal.
Cellectar Biosciences Inc (CLRB) Momentum (MOM) is 0.030, creating a Buy signal.
Cellectar Biosciences Inc (CLRB) Moving Average Convergence Divergence (MACD) is -0.140, creating a Sell signal.
Cellectar Biosciences Inc (CLRB) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.232 | Buy |
| MA_10 | 1.224 | Buy |
| MA_20 | 1.230 | Buy |
| MA_60 | 1.890 | Sell |
| MA_200 | 2.573 | Sell |
| MA_250 | 2.718 | Sell |
Cellectar Biosciences Inc (CLRB) 5-Day simple moving average is 1.232, while Cellectar Biosciences Inc (CLRB) share price is $, making it a Buy.
Cellectar Biosciences Inc (CLRB) 10-Day simple moving average is 1.224, while Cellectar Biosciences Inc (CLRB) share price is $, making it a Buy.
Cellectar Biosciences Inc (CLRB) 20-Day simple moving average is 1.230, while Cellectar Biosciences Inc (CLRB) share price is $, making it a Buy.
Cellectar Biosciences Inc (CLRB) 60-Day simple moving average is 1.890, while Cellectar Biosciences Inc (CLRB) share price is $, making it a Sell.
Cellectar Biosciences Inc (CLRB) 200-Day simple moving average is 2.573, while Cellectar Biosciences Inc (CLRB) share price is $, making it a Sell.
Cellectar Biosciences Inc (CLRB) 250-Day simple moving average is 2.718, while Cellectar Biosciences Inc (CLRB) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.